Revvity, Inc. and Element Biosciences, Inc., announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples.
Revvity Omics has recently adopted Element’s AVITI platform for its global service business.
Revvity and Element Biosciences plan to make the combined solution available to an expanded customer base interested in the full workflow or specific modules.
Summary of collaboration:
- Next generation sequencing workflow with research use only components from both companies is designed to provide flexibility, time and cost savings.
- Neonatal research applications have been identified as a focus area.
- Laboratory needs can be addressed with turn-key solutions or modular components.